Uniquely Similar
Biologics are unique and complex molecules and biosimilars are highly similar to the reference biologic.1 Teva has a legacy of value-based generics and branded products. Now Teva is also focusing on biosimilars and educating on the science behind these medicines.
Reference: 1. US Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Scientific Considerations in Demonstrating Biosimilarity to a Reference Product. Guidance for Industry. April 2015. https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm291128.pdf. Accessed June 25, 2018.